Blog

APCARI > Blog > Publications > Metastasis as a therapeutic target in prostate cancer: a conceptual framework > Metastasis as a therapeutic target in prostate cancer a conceptual framework

Metastasis as a therapeutic target in prostate cancer a conceptual framework

By:

Metastasis as a therapeutic target in prostate cancer a conceptual framework

Stay Informed

To stay up to date on all the latest news and publications, subscribe to our newsletter!

Recent Posts

Could there soon be a better way to diagnose prostate cancer? Posted on May 31 17 at 7:03pm
Member of the APCaRI Training Program will present a poster at CARO ASM 2017 - Toronto Posted on Apr 21 17 at 2:09pm
New platform for prostate cancer diagnosis to be presented at ISEV 2017 Posted on Apr 21 17 at 1:09pm

Russ Greiner’s Team “PC LEARN”, tied for 1st in the Prostate Cancer DREAM Challenge

Competing with 50 teams from around the world in the Prostate Cancer DREAM Challenge, University of Alberta’s PC LEARN team tied for 1st in one of the 3 sub-challenges
to predict the survival and toxicity of Docetaxel treatment in patients with metastatic castrate resistant prostate cancer!

“The DREAM Challenge was an exciting opportunity for us to apply machine learning to real medical data and possibly to contribute to medical research.” said lead PI and APCaRI member Russ Greiner.

The primary benefit of this Challenge will be to establish new quantitative benchmarks for prognostic modeling in mCRPC, with a potential impact for clinical decision making and ultimately understanding the mechanism of disease progression. https://www.synapse.org/#!Synapse:syn2813558/wiki/70844

- Russ Greiner